Rapamycin conjugates and antibodies

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S403000, C435S345000, C435S346000, C435S070210

Reexamination Certificate

active

07897733

ABSTRACT:
Provided are rapamycin conjugates which are useful as immunogenic molecules for the generation of antibodies specific for rapamycin, for measuring levels of rapamycin or derivatives thereof; for isolating rapamycin binding proteins; and detecting antibodies specific for rapamycin or derivatives thereof. This invention also provides a rapamycin specific monoclonal antibody.

REFERENCES:
patent: 3929992 (1975-12-01), Sehgal
patent: 3993749 (1976-11-01), Sehgal et al.
patent: 4208479 (1980-06-01), Zuk et al.
patent: 4316885 (1982-02-01), Rakhit
patent: 4401653 (1983-08-01), Eng
patent: 4650803 (1987-03-01), Stella
patent: 4885171 (1989-12-01), Surendra
patent: 5023264 (1991-06-01), Caufield et al.
patent: 5078999 (1992-01-01), Warner
patent: 5080899 (1992-01-01), Sturm
patent: 5089390 (1992-02-01), Davalian
patent: 5091389 (1992-02-01), Ondeyka
patent: 5100883 (1992-03-01), Schiehser
patent: 5100899 (1992-03-01), Calne
patent: 5102876 (1992-04-01), Caufield
patent: 5118677 (1992-06-01), Caufield
patent: 5118678 (1992-06-01), Kao
patent: 5120842 (1992-06-01), Failli
patent: 5122511 (1992-06-01), Patchett
patent: 5130307 (1992-07-01), Failli
patent: 5138051 (1992-08-01), Hughes
patent: 5151413 (1992-09-01), Caufield
patent: 5164495 (1992-11-01), Lunetta
patent: 5169773 (1992-12-01), Rosenthaler
patent: 5169851 (1992-12-01), Hughes
patent: 5177203 (1993-01-01), Failli
patent: 5194447 (1993-03-01), Kao
patent: 5233036 (1993-08-01), Hughes
patent: 5252579 (1993-10-01), Skotnicki
patent: 5504091 (1996-04-01), Molnar-Kimber
patent: 5532137 (1996-07-01), Niwa
patent: 5665772 (1997-09-01), Cottens
patent: 5912253 (1999-06-01), Cottens
patent: 5985890 (1999-11-01), Cottens
patent: 6187547 (2001-02-01), Legay
patent: 6328970 (2001-12-01), Molnar-Kimber et al.
patent: 6541612 (2003-04-01), Molnar-Kimber et al.
patent: 6635745 (2003-10-01), Sedrani et al.
patent: 7279561 (2007-10-01), Molnar-Kimber et al.
patent: 2002/0002273 (2002-01-01), Sedrani et al.
patent: 2002/0022717 (2002-02-01), Sedrani et al.
patent: 0 201751 (1986-11-01), None
patent: 283801 (1988-03-01), None
patent: 473961 (1991-08-01), None
patent: 487289 (1991-11-01), None
patent: 467606 (1992-01-01), None
patent: 506032 (1992-03-01), None
patent: 507555 (1992-03-01), None
patent: 525960 (1992-06-01), None
patent: 693132 (1996-01-01), None
patent: 63-219394 (1988-09-01), None
patent: WO 90/08957 (1990-08-01), None
patent: WO 90/06763 (1990-09-01), None
patent: WO 92/05179 (1992-04-01), None
patent: WO 92/22332 (1992-12-01), None
patent: WO 93 19752 (1993-10-01), None
patent: WO 93 25533 (1993-12-01), None
patent: WO 94/24304 (1994-10-01), None
Nolli et al. Antibodies against the antibiotics: an overview. Ann Ist Super Sanita 1991, vol. 27, Issue 1, pp. 149-154.
Hultsch et al,Proceedings of the National Academy of Sciences of USA, 88:6229-6233 (1991).
Chen et al,Journal of the American Chemical Society, 116:2683-2684 (1994).
Sevier et al,Clin. Chem., 27(11):1797-1806 (1981).
Yelton et al,American Scientist, 68:510-516 (1980).
Campbell et al,Monoclonal Antibody and Immunosensor Technology, Elsevier, Chapter 1 (1991).
Linskins et al,Immunology in Plant Sciences, pp. 86-141 (1986).
Holt et al,Chemical Abstracts, vol. 120, No. 25 (1994).
Venzina et al,J. Antibiot., 28:721 (1975).
Sehgal,J. Antibiot., 28:727 (1975).
Baker,Antibiot., 31:539 (1978).
Martel,Can. J. Physiol. Pharmacol., 55:48 (1997).
Staruch,FASEB, 3:3411 (1989).
Dumont,FASEB, 3:5256 (1989).
Caine,Lancet, p. 1183 (1978).
Morris,Med. Sci. Res., 17:877 (1989).
Baeder,Fifth Int. Conf. Inflamm. Res. Assoc., Abstract, p. 121 (1990).
Gregory,J. Heart Lung Transplant.,11(pt 2):197 (1992).
Meiser,J. Heart Lung Transplant., 9:55 (1992).
Stepkowski,Transplantation Proceedings, 21(1):507-508 (1991).
Tamura,Transplantation Proceedings, 19(6):23-29 (1987).
Cadoff,Transplantation Proceedings, 22(1):50-51 (1990).
Propper, et al, FK506-Its Influence on Anti-Class 1 MHC Alloantibody Responses to Blood Transfusions, Transplantation, Aug. 1990, pp. 267-271, vol. 50, No. 2.
Tsuji, et al, Selective Immunosuppression of Prodigiosin 25-C and FK506 in the Murine Immune System, Oct. 1990, pp. 1293-1301, vol. 43, No. 10.
Van Duyne, et al, Atomic Structure of the Rapamycin Human Immunophilin FKBP-12 Complex, 1991, pp. 7433-7434, vol. 113.
Woo, et al, Spleen lymphocyte populations and expression of activation markers in rats treated with the potent new immunosuppressive agent FK-506, 1988, pp. 153-155, vol. 65.
English-language translation of Jun. 10, 2003 Official Action in Japanese Patent Application No. 524408/94.
English-language translation of May 11, 2004 Official Action in Japanese Patent Application No. 524408/94.
English-language translation of Sep. 29, 2009 Official Action on Appeal in Japanese Patent Application No. 524408/94 (Appeal No. 2006-5134).
English-language translation of Sep. 28, 2004 Official Action in Japanese Patent Application No. 2003-412071.
English-language translation of Dec. 13, 2005 Official Action in Japanese Patent Application No. 2003-412071.
English-language translation of Sep. 29, 2009 Official Action on Appeal in Japanese Patent Application No. 2003-412071 (Appeal No. 2006-4633).
English-language translation of Abstract of JP-63-219394 (Cite No. 3 herein).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Rapamycin conjugates and antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rapamycin conjugates and antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapamycin conjugates and antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2746737

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.